thrombotic microangiopathies
Showing 1 - 18 of 18
Early Diagnosis of Transplant-associated Thrombotic
Not yet recruiting
- Thrombotic Microangiopathies
- Hematopoietic Stem Cell Transplantation
- (no location specified)
Oct 22, 2023
Thrombotic Microangiopathy Associated With Mitomycin C, Treated
Recruiting
- Thrombotic Microangiopathies
-
Strasbourg, FranceService de Néphrologie, Dialyse et Transplantation - CHU de Stra
Oct 18, 2023
Alert, and Rapid Diagnosis of Thrombotic Microangiopathies:
Not yet recruiting
- Thrombotic Microangiopathies
- (no location specified)
Aug 10, 2023
Thrombotic Microangiopathies, Hematopoietic Stem Cell Transplantation Trial in Worldwide (Biological: narsoplimab)
Recruiting
- Thrombotic Microangiopathies
- Hematopoietic Stem Cell Transplantation
- Biological: narsoplimab
-
San Diego, California
- +16 more
May 2, 2023
Thrombotic Microangiopathies Trial in Amiens, Rouen (Eculizumab administration)
Not yet recruiting
- Thrombotic Microangiopathies
- Eculizumab administration
-
Amiens, France
- +1 more
Jan 18, 2023
Thrombotic Microangiopathies, Atypical Hemolytic Uremic Syndrome, Multiple Organ Dysfunction Syndrome Trial in Los Angeles,
Completed
- Thrombotic Microangiopathies
- +2 more
-
Los Angeles, California
- +2 more
Jan 17, 2023
Covid19, Thrombotic Microangiopathies, Acute Kidney Injury Trial in Boston (Ravulizumab)
Active, not recruiting
- Covid19
- +2 more
-
Boston, MassachusettsBrigham and Women's Hospital
Dec 31, 2022
Thrombotic Microangiopathies Trial in Suzhou (collection data)
Recruiting
- Thrombotic Microangiopathies
- collection data
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Nov 22, 2022
Study in Adult and Pediatric Patients With HSCT-TMA
Withdrawn
- Stem Cell Transplant Complications
- Thrombotic Microangiopathies
- No intervention
-
Salt Lake City, UtahClinical Trial Site
May 9, 2022
Thrombotic Microangiopathies, Hematologic Diseases Trial in Suzhou (N-Acetylcysteine, Placebo Oral Tablet)
Completed
- Thrombotic Microangiopathies
- Hematologic Diseases
- N-Acetylcysteine
- Placebo Oral Tablet
-
Suzhou, Jiangsu, ChinaThe First affiliated Hospital of SooChow University
Jan 19, 2022
Thrombotic Microangiopathies Trial in San Francisco (Defibrotide)
Completed
- Thrombotic Microangiopathies
-
San Francisco, CaliforniaBenioff Children's Hospital at UCSF Medical Center
Sep 14, 2021
Thrombotic Microangiopathies, Hemolytic Uremic Syndrome, Atypical, Hemolytic-Uremic Syndrome Trial in Maastricht
Recruiting
- Thrombotic Microangiopathies
- +2 more
-
Maastricht, Limburg, NetherlandsMaastricht University Medical Center
Aug 17, 2021
Thrombotic Microangiopathies Trial in Worldwide (OMS721)
Completed
- Thrombotic Microangiopathies
- OMS721
-
Duarte, California
- +24 more
Jul 1, 2021
Thrombotic Microangiopathies Trial in Durham (nomacopan (rVA576))
Recruiting
- Thrombotic Microangiopathies
- nomacopan (rVA576)
-
Durham, North CarolinaDuke University Medical Center, Children's Health Center
Mar 4, 2021
Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura Trial in Paris (Biological and imaging investigations)
Completed
- Thrombotic Microangiopathies
- Thrombotic Thrombocytopenic Purpura
- Biological and imaging investigations
-
Paris, FranceSaint Antoine
Jul 23, 2019
Thrombotic Microangiopathies, Atypical Hemolytic Uremic Syndrome Trial in Los Angeles, Chicago (OMS721)
Unknown status
- Thrombotic Microangiopathies
- Atypical Hemolytic Uremic Syndrome
- OMS721
-
Los Angeles, California
- +1 more
Oct 17, 2018
TTP and aHUS in Complicated Pregnancies
Unknown status
- Thrombotic Thrombocytopenic Purpura
- +7 more
- ADAMTS 13, complement and angiogenic biomarkers
-
London, United KingdomUniversity College London Hospital
Sep 21, 2018
Screening of TMA Patients für ADAMTS13 Activity (Adamscreen)
Unknown status
- Thrombotic Microangiopathies
- Technozyme
- (no location specified)
Feb 20, 2015